{"brief_title": "Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer", "brief_summary": "The purpose of this study is to compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and whose disease has worsened after treatment with irinotecan.", "condition": ["Colorectal Neoplasms", "Colonic Neoplasms", "Rectal Neoplasms"], "intervention_type": ["Drug"], "intervention_name": ["Vatalanib"], "arm_group_label": ["1", "2"], "other_name": ["PTK787/ZK 222584"], "criteria": "Inclusion criteria - Confirmed adenocarcinoma of the colon or rectum in patients with metastatic disease - One prior chemotherapy regimen with irinotecan and 5FU - Evidence of progressive disease within 6 months after last dose of irinotecan - WHO Performance Status of 0, 1, or 2 - Measurable tumors - Adequate hematologic status, liver and kidney function - Life expectancy greater than 12 weeks - Written informed consent obtained Exclusion criteria - History or presence of central nervous system disease - Patients with a history of another primary cancer within 5 years - Prior chemotherapy within 3 weeks before entry to study - Major surgery within 4 weeks or minor surgery within 2 weeks before entry to study - Investigational drugs within 4 weeks before entry to study - Prior therapy with oxaliplatin - Peripheral neuropathy with functional impairment - Female patients who are pregnant or breast feeding - Any severe or uncontrolled medical condition which could prevent participation in study - Chronic kidney disease - Acute or chronic liver disease - Patients taking Coumadin", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Colorectal Tumor", "mesh_term": ["Neoplasms", "Colorectal Neoplasms", "Rectal Neoplasms", "Colonic Neoplasms", "Oxaliplatin", "Vatalanib"], "id": "NCT00056446"}